Lataa...

Epigenetic Silencing of Immune-Checkpoint Receptors in Bone Marrow- Infiltrating T Cells in Acute Myeloid Leukemia

BACKGROUND: Immune-checkpoint (IC) inhibitors have revolutionized the treatment of multiple solid tumors and defined lymphomas, but they are largely ineffective in acute myeloid leukemia (AML). The reason why especially PD1/PD-L1 blocking agents are not efficacious is not well-understood but it may...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Oncol
Päätekijät: Radpour, Ramin, Stucki, Miriam, Riether, Carsten, Ochsenbein, Adrian F.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2021
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8130556/
https://ncbi.nlm.nih.gov/pubmed/34017684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.663406
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!